Among many biomarkers of cancer, IGF-2 and IGFBP-2 expression is upregulated in many types of cancer and is associated with an increased risk of developing cancers (15–17) therefore frequently considered as neoplastic marker (18–20). This evidence concerns the gene IGFBP2 and cancer.